Correlation
The correlation between CORT and ETN is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
CORT vs. ETN
Compare and contrast key facts about Corcept Therapeutics Incorporated (CORT) and Eaton Corporation plc (ETN).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CORT or ETN.
Performance
CORT vs. ETN - Performance Comparison
Loading data...
Key characteristics
CORT:
1.22
ETN:
-0.03
CORT:
4.03
ETN:
0.14
CORT:
1.55
ETN:
1.02
CORT:
4.00
ETN:
-0.10
CORT:
10.24
ETN:
-0.24
CORT:
17.78%
ETN:
14.17%
CORT:
121.27%
ETN:
38.49%
CORT:
-94.28%
ETN:
-68.95%
CORT:
-32.03%
ETN:
-13.35%
Fundamentals
CORT:
$8.23B
ETN:
$128.41B
CORT:
$1.16
ETN:
$9.84
CORT:
66.94
ETN:
33.10
CORT:
0.61
ETN:
2.73
CORT:
12.01
ETN:
5.07
CORT:
12.05
ETN:
6.89
CORT:
$685.45M
ETN:
$25.31B
CORT:
$674.70M
ETN:
$9.73B
CORT:
$111.33M
ETN:
$5.80B
Returns By Period
In the year-to-date period, CORT achieves a 54.08% return, which is significantly higher than ETN's -1.43% return. Over the past 10 years, CORT has outperformed ETN with an annualized return of 28.74%, while ETN has yielded a comparatively lower 19.48% annualized return.
CORT
54.08%
6.02%
32.49%
146.24%
54.63%
38.67%
28.74%
ETN
-1.43%
12.13%
-12.06%
-1.12%
34.58%
33.23%
19.48%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CORT vs. ETN — Risk-Adjusted Performance Rank
CORT
ETN
CORT vs. ETN - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Corcept Therapeutics Incorporated (CORT) and Eaton Corporation plc (ETN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
CORT vs. ETN - Dividend Comparison
CORT has not paid dividends to shareholders, while ETN's dividend yield for the trailing twelve months is around 1.22%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CORT Corcept Therapeutics Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ETN Eaton Corporation plc | 1.22% | 1.13% | 1.43% | 2.06% | 1.76% | 2.43% | 3.00% | 3.85% | 3.04% | 3.40% | 4.23% | 2.88% |
Drawdowns
CORT vs. ETN - Drawdown Comparison
The maximum CORT drawdown since its inception was -94.28%, which is greater than ETN's maximum drawdown of -68.95%. Use the drawdown chart below to compare losses from any high point for CORT and ETN.
Loading data...
Volatility
CORT vs. ETN - Volatility Comparison
Corcept Therapeutics Incorporated (CORT) has a higher volatility of 9.39% compared to Eaton Corporation plc (ETN) at 6.42%. This indicates that CORT's price experiences larger fluctuations and is considered to be riskier than ETN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
CORT vs. ETN - Financials Comparison
This section allows you to compare key financial metrics between Corcept Therapeutics Incorporated and Eaton Corporation plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CORT vs. ETN - Profitability Comparison
CORT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported a gross profit of 154.81M and revenue of 157.21M. Therefore, the gross margin over that period was 98.5%.
ETN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Eaton Corporation plc reported a gross profit of 2.45B and revenue of 6.38B. Therefore, the gross margin over that period was 38.4%.
CORT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported an operating income of 3.42M and revenue of 157.21M, resulting in an operating margin of 2.2%.
ETN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Eaton Corporation plc reported an operating income of 1.20B and revenue of 6.38B, resulting in an operating margin of 18.8%.
CORT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Corcept Therapeutics Incorporated reported a net income of 20.29M and revenue of 157.21M, resulting in a net margin of 12.9%.
ETN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Eaton Corporation plc reported a net income of 964.00M and revenue of 6.38B, resulting in a net margin of 15.1%.